´
G. MLOSTON AND H. HEIMGARTNER
1240
188.0617. Anal. Calcd. for C7H12N2O2S (188.25): C 44.66, H 6.43. Found: C 44.55, H
6.49.
1-Dimethoxymethyl-3,4,5-trimethylimidazole-2(3H)-thione (7b). Yield:
188 mg (87%). Colorless plates, mp 70–71◦C (petroleum ether/CH2Cl2). IR (KBr): 3009w,
2943m, 2928m, 2837m, 1666w, 1459m, 1437m, 1395vs, 1376s, 1367s, 1330vs, 1224s,
1200m, 1112vs, 1094vs, 1075vs, 1021m, 996s, 978m, 871m. 1H-NMR (CDCl3): 2.08, 2.20
(2s, 2 Me), 3.42 (s, 2 MeO), 3.55 (s, MeN), 6.87 (s, (MeO)2CH). 13C-NMR (CDCl3):
8.0, 8.2 (2 Me), 30.8 (MeN), 54.2 (2 MeO), 105.3 ((MeO)2CH), 119.5, 121.5 (2 Cq,
imidazole), 161.3 (C S). EI-MS: 216 42, M+.), 185 (33), 157 (12), 156 (93), 155 (10), 143
(7), 142 (62), 141 (32), 123 (44), 109 (11), 75 (100). HR-EI-MS: Calcd. for C9H16N2O2S:
216.0932; found: 216.0933. Anal. Calcd. for C9H16N2O2S (216.30): C 49.97, H 7.46.
Found: C 50.10, H 7.31.
1-Dimethoxymethyl-3-butyl-4,5-dimethylimidazole-2(3H)-thione (7c).
Yield: 190 mg (74%). Colorless oil, purified by microdistillation. IR (neat): 2957s, 2935s,
2872m, 1657m, 1443s, 1410s, 1389s, 1329s, 1220s, 1194s, 1105s, 1070s, 992m, 869m.
1H-NMR (CDCl3): 0.95 (t, JH,H = 7.3 Hz, MeCH2), 1.15–1.95 (m, -CH2-CH2-), 2.09,
2.30 (2s, 2 Me), 3.43 (s, 2 MeO), 4.02 (t, JH,H = 7.2 Hz, CH2N), 6.89 (s, (MeO)2CH).
13C-NMR (CDCl3): 8.3, 8.7, 13.4 (3 Me), 19.7, 30.3 (2 CH2), 44.4 (CH2N), 54.7 (2 MeO),
105.7 ((MeO)2CH), 120.3, 121.5 (2 Cq, imidazole), 161.5 (C S). EI-MS: 258 (8, M+.),
227 (8), 198 (36), 184 (10), 183 (11), 169 (15), 151 (23), 142 (11), 141 (8), 128 (9), 127
(10), 123 (8), 116 (17), 109 (17), 101 (8), 75 (100). HR-EI-MS: Calcd. for C12H22N2O2S:
258.1402; found: 258.1398. Anal. Calcd. for C12H22N2O2S (258.38): C 55.78, H 8.58.
Found: C 55.90, H 8.32.
1-Dimethoxymethyl-3-cyclohexyl-4,5-dimethylimidazole-2(3H)-thione
(7d). Yield: 187 mg (66%). Colorless plates, mp 84–86◦C (petroleum ether/CH2Cl2).
IR (KBr): 2954s, 2851w, 1649w, 1447w, 1405s, 1377vs, 1362s, 1335s, 1219m, 1189m,
1200m, 1108vs, 1067vs, 993s, 859m. 1H-NMR (CDCl3): 2.18 (br. s, 2 Me), 1.00–2.30 (m,
10H, 5 CH2), 3.43 (s, 2 MeO), 5.15 (m, CH), 6.98 (s, (MeO)2CH). 13C-NMR (CDCl3):
8.5, 10.3 (2 Me), 25.1, 25.8, 30.3 (5 CH2), 54.7 (2 MeO), 57.0 (CHN), 106.0 ((MeO)2CH),
120.9, 121.5 (2 Cq, imidazole), 161.5 (C S). EI-MS: 284 (26, M+.), 253 (17), 225 (9),
224 (57), 210 (13), 209 (10), 171 (7), 143 (10), 142 (91), 141 (9), 128 (36), 127 (16), 109
(61), 75 (100). HR-EI-MS: Calcd. for C14H24N2O2S: 284.1558; found: 284.1553. Anal.
Calcd. for C14H24N2O2S (284.42): C 59.12, H 8.51. Found: C 59.27, H 8.77.
X-Ray Crystal-Structure Determination of 7b
All measurements were performed on a Nonius KappaCCD area-diffractometer26 us-
ing graphite-monochromated MoKα radiation (λ 0.71073 Å) and an Oxford Cryosystems
Cryostream 700 cooler. The data collection and refinement parameters are given below,27
and a view of the molecule is shown in Figure 1. Data reduction was performed with HKL
Denzo and Scalepack.28 The intensities were corrected for Lorentz and polarization effects,
and an absorption correction based on the multi-scan method29 was applied. Equivalent
reflections were merged. The structure was solved by direct methods using SIR92,30 which
revealed the positions of all non-H-atoms. The non-H-atoms were refined anisotropically.
All of the H-atoms were placed in geometrically calculated positions and refined using a
riding model where each H-atom was assigned a fixed isotropic displacement parameter
with a value equal to 1.2Ueq of its parent C-atom (1.5Ueq for the methyl groups). The